Scholarlink

Background <p>The study compared the characteristics of women undergoing Medtronic Hugo™ robotically assisted surgery (RAS) versus laparoscopic surgery (LS) for benign hysterectomy at two hospitals in Panama. It also analyzed the types of surgery associated with shorter operating times.</p> Methods <p>We performed a retrospective secondary data analysis of clinical records, from 63 women who underwent RAS and 59 who had LS, between July 1, 2022, and June 29, 2023. We analyzed age, body mass index (BMI), indications for hysterectomy, surgical type, time, complications, and hospital stays using Chi-square tests, Wilcoxon rank sum tests, and multivariable linear regression.</p> Results <p>Compared to women who underwent LS, those in the RAS group were older and had lower BMI (<i>p</i> = 0.018). Surgical time and blood loss were lower in the RAS group (76&#xa0;min vs. 117&#xa0;min and 30&#xa0;ml vs. 200&#xa0;ml, <i>p</i> &lt; 0.001). No complications occurred in either group. RAS was associated with a 22% reduction in surgical time after controlling for patients’ age, BMI, preoperative diagnoses, uterine weight, and blood loss during surgery (p 0.005).</p> Conclusion <p>Hugo™ RAS showed a good safety profile and shorter operating time compared to laparoscopic hysterectomy, in contrast to previous research that indicated longer RAS durations.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hugo™ robotically assisted surgery versus laparoscopic hysterectomy for benign gynecological diseases: a secondary data analysis of clinical records in Panama

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月11日

查看全文
  • Carlos Enrique Vargas Castillo,
  • Miguel Ángel Cáceres Yap,
  • Svetlana V. Doubova,
  • Ricardo Pérez Cuevas,
  • Aneth Bonilla Cruz

摘要

Background

The study compared the characteristics of women undergoing Medtronic Hugo™ robotically assisted surgery (RAS) versus laparoscopic surgery (LS) for benign hysterectomy at two hospitals in Panama. It also analyzed the types of surgery associated with shorter operating times.

Methods

We performed a retrospective secondary data analysis of clinical records, from 63 women who underwent RAS and 59 who had LS, between July 1, 2022, and June 29, 2023. We analyzed age, body mass index (BMI), indications for hysterectomy, surgical type, time, complications, and hospital stays using Chi-square tests, Wilcoxon rank sum tests, and multivariable linear regression.

Results

Compared to women who underwent LS, those in the RAS group were older and had lower BMI (p = 0.018). Surgical time and blood loss were lower in the RAS group (76 min vs. 117 min and 30 ml vs. 200 ml, p < 0.001). No complications occurred in either group. RAS was associated with a 22% reduction in surgical time after controlling for patients’ age, BMI, preoperative diagnoses, uterine weight, and blood loss during surgery (p 0.005).

Conclusion

Hugo™ RAS showed a good safety profile and shorter operating time compared to laparoscopic hysterectomy, in contrast to previous research that indicated longer RAS durations.

Clinical trial number

Not applicable.